3) In a previous analysis they also looked at genes that are protective for ME/CFS and several were involved in type-2 diabetes, insulin-related signalling, BMI, etc. That's another reason why they are interested in the GLP-1 drugs.
Link:
Actively protective combinatorial analysis: A scalable novel method for detecting variants that contribute to reduced disease prevalence in high-risk individuals
We present a novel method for routinely identifying disease resilience associations that offers powerful insights for the discovery of a new class of …